statistiche ricercatore

Continente	#
AS - Asia	555
NA - Nord America	419
EU - Europa	271
SA - Sud America	35
AF - Africa	22
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.305

Nazione	#
US - Stati Uniti d'America	414
SG - Singapore	156
VN - Vietnam	155
CN - Cina	146
DE - Germania	51
GB - Regno Unito	47
IT - Italia	37
HK - Hong Kong	31
BR - Brasile	23
NL - Olanda	22
FR - Francia	20
SE - Svezia	20
KR - Corea	15
RU - Federazione Russa	14
BG - Bulgaria	10
FI - Finlandia	10
IE - Irlanda	9
IN - India	9
JP - Giappone	9
TH - Thailandia	7
ID - Indonesia	6
PH - Filippine	6
UA - Ucraina	6
ZA - Sudafrica	6
CH - Svizzera	5
SC - Seychelles	5
AR - Argentina	4
BE - Belgio	4
EE - Estonia	4
JO - Giordania	4
TG - Togo	4
BD - Bangladesh	3
CA - Canada	3
CI - Costa d'Avorio	3
EC - Ecuador	3
AT - Austria	2
CL - Cile	2
CZ - Repubblica Ceca	2
EG - Egitto	2
ES - Italia	2
IQ - Iraq	2
LT - Lituania	2
MX - Messico	2
TR - Turchia	2
A2 - ???statistics.table.value.countryCode.A2???	1
AF - Afghanistan, Repubblica islamica di	1
AU - Australia	1
CO - Colombia	1
ET - Etiopia	1
IR - Iran	1
KE - Kenya	1
KZ - Kazakistan	1
LU - Lussemburgo	1
MD - Moldavia	1
NZ - Nuova Zelanda	1
PL - Polonia	1
PY - Paraguay	1
RO - Romania	1
TJ - Tagikistan	1
VE - Venezuela	1
Totale	1.305

Nome	#
DNA Damage Detection by 53BP1: Relationship to Species Longevity	220
Characterization of tumor cells using a medical wire for capturing circulating tumor cells: A 3D approach based on immunofluorescence and DNA FISH	176
A cell culture comparative biology approach to study mechanisms of genomic stability and their relevance for species longevity: a newer interpretation of 53BP1 nuclear foci	174
A cell culture comparative biology approach to study mechanisms of genome stability and their relevance for species longevity: a newer interpretation of DNA damage induced nuclear foci	171
Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors	158
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension	111
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future	89
Fully human antibodies for malignant pleural mesothelioma targeting	89
Delta-like ligand 3 (DLL3): an attractive actionable target in tumors with neuroendocrine origin	74
PSMA expression: A potential ally for the pathologist in prostate cancer diagnosis	73
Totale	1.335

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	50	0	0	0	0	0	0	0	0	0	1	2	47
2021/2022	88	15	2	4	7	6	3	1	5	10	7	17	11
2022/2023	107	11	9	7	16	2	6	1	4	19	4	10	18
2023/2024	98	12	13	8	13	24	15	3	4	1	1	0	4
2024/2025	273	15	43	13	20	51	12	19	15	3	30	13	39
2025/2026	554	66	66	40	56	59	27	57	28	118	37	0	0
Totale													1.335

CRIS Current Research Information System